In a meta-analysis of 46 RCTs, behavioral interventions modestly improved HbA1c in youth with T1D; family-focused approaches worked best.
|Articles|August 12, 2020
Practice Resources & FAQ
Our practice resources and frequently asked questions page seeks to answer any inquiry you may have related to professional practice.
Advertisement
NAPNAP’s mission is to empower pediatric-focused advanced practice registered nurses and key partners to optimize child and family health. We offer a variety of free, high-quality
Advertisement
Related to this article
A GBD analysis of 204 countries estimated measles cases in children under 5 rose from 11.1 million in 2019 to 15.6 million in 2023.
Missed the AAP's new pediatric UTI guideline? This easy-to-read FAQ covers the key changes in diagnosis, treatment, imaging, and prevention.
Christina Boull, MD, explains how pediatricians can recognize dermatologic conditions in darker skin tones and address pigment changes and treatment gaps.
Tezepelumab produced histologic remission in up to 68.9% of patients aged 12+ with EoE vs 3.5% with placebo at week 24, sustained to week 52.
Black race was the strongest predictor of T2-high inflammation in 451 children with severe asthma adjusted for social and environmental factors.
Researchers discuss how testosterone changes during early puberty may influence depression and anxiety symptoms in girls and implications for pediatricians.
A Mott Poll of 2,027 parents found 81% say having a baby costs too much; 73% strongly back state paid leave around birth.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Recognizing skin conditions in children with darker skin tones
2
FAQ: How should pediatricians manage UTIs under new AAP guidance?
3
Global measles cases in children under 5 up 40% since COVID-19
4
Tezepelumab sustains EoE remission through 52 weeks
5